Patent 7419997 was granted and assigned to Smithkline Beecham Limited on September, 2008 by the United States Patent and Trademark Office.
The present invention relates to novel compounds that are useful in the treatment of human papillomaviruses, and also to the methods for the making and use of such compounds.